High intensity focused ultrasound for the treatment of solid tumors: a pilot study in canine cancer patients

References

• Izadifar Z, Izadifar Z, Chapman D, et al. An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications. J Clin Med. 2020;9(2):460.
   PubMed Web of Science ®Google Scholar
• Poissonnier L, Chapelon J-Y, Rouvière O, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol. 2007;51(2):381–387.
   PubMed Web of Science ®Google Scholar
• Peek MCL, Wu F. High-intensity focused ultrasound in the treatment of breast tumours. Ecancermedicalscience. 2018;12:794–794.
   PubMed Web of Science ®Google Scholar
• Pron G. Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser. 2015;15(4):1–86.
   Google Scholar
• Yeo SY, Elevelt A, Donato K, et al. Bone metastasis treatment using magnetic resonance-guided high intensity focused ultrasound. Bone. 2015;81:513–523.
   PubMed Web of Science ®Google Scholar
• Dababou S, Marrocchio C, Rosenberg J, et al. A meta-analysis of palliative treatment of pancreatic cancer with high intensity focused ultrasound. J Ther Ultrasound. 2017;5:9–9.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. Int J Obstet Gy. 2018;125(3):354–364.
   PubMed Web of Science ®Google Scholar
• Idbaih A, Canney M, Belin L, et al. Safety and feasibility of repeated and transient blood-brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma. Clin Cancer Res. 2019;25(1):3793–3801.
   PubMed Web of Science ®Google Scholar
• Rosenhammer B, Ganzer R, Zeman F, et al. Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis. World J Urol. 2019;37(10):2073–2080.
   PubMed Web of Science ®Google Scholar
• Izadifar Z, Babyn P, Chapman D. Mechanical and biological effects of ultrasound: a review of present knowledge. Ultrasound Med Biol. 2017;43(6):1085–1104.
   PubMed Web of Science ®Google Scholar
• Maloney E, Hwang JH. Emerging HIFU applications in cancer therapy. Int J Hyperthermia. 2015;31(3):302–309.
   PubMed Web of Science ®Google Scholar
• Hölscher T, Fisher DJ, Ahadi G, et al. Introduction of a rabbit carotid artery model for sonothrombolysis research. Transl Stroke Res. 2012;3(3):397–407.
   PubMed Web of Science ®Google Scholar
• Hölscher T, Fisher DJ, Raman R, et al. Noninvasive transcranial clot lysis using high intensity focused ultrasound. J Neurol Neurophysiol. 2011;01(01):1–7.
   Google Scholar
• Hölscher T, Raman R, Fisher DJ, et al. Effects of varying duty cycle and pulse width on high-intensity focused ultrasound (HIFU)-induced transcranial thrombolysis. J Ther Ultrasound. 2013;1(1):18.
   PubMedGoogle Scholar
• Yu MH, Lee JY, Kim HR, et al. Therapeutic effects of microbubbles added to combined High-Intensity focused ultrasound and chemotherapy in a pancreatic cancer xenograft model. Korean J Radiol. 2016;17(5):779–788.
   PubMed Web of Science ®Google Scholar
• Togtema M, Pichardo S, Jackson R, et al. Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes. PLoS One. 2012;7(11):e50730-e50730.
   Web of Science ®Google Scholar
• Kotopoulis S, et al. Sonoporation: from the lab to human clinical trials. In 2014 IEEE International Ultrasonics Symposium. 2014.
   Google Scholar
• Wu F, Zhou L, Chen WR. Host antitumour immune responses to HIFU ablation. Int J Hyperthermia. 2007;23(2):165–171.
   PubMed Web of Science ®Google Scholar
• Ran L-F, Xie X-P, Xia J-Z, et al. Specific antitumour immunity of HIFU-activated cytotoxic T lymphocytes after adoptive transfusion in tumour-bearing mice. Int J Hyperthermia. 2016;32(2):204–210.
   PubMed Web of Science ®Google Scholar
• van den Bijgaart RJE, Eikelenboom DC, Hoogenboom M, et al. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol Immunother. 2017;66(2):247–258.
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y, et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007;5(1):34–34.
   PubMed Web of Science ®Google Scholar
• Liu F, Hu Z, Qiu L, et al. Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation. J Transl Med. 2010;8:7–7.
   PubMed Web of Science ®Google Scholar
• Xu Z-L, Zhu X-Q, Lu P, et al. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer. Ultrasound Med Biol. 2009;35(1):50–57.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang Y, Feng J, et al. Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses. Ultrasound Med Biol. 2010;36(3):441–448.
   PubMed Web of Science ®Google Scholar
• Xia J-Z, Xie F-L, Ran L-F, et al. High-intensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic T lymphocytes. Ultrasound Med Biol. 2012;38(8):1363–1371.
   PubMed Web of Science ®Google Scholar
• Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS). four ablation treatments of a single canine hepatocellular adenoma. HPB. 2006;8(4):292–298.
   PubMedGoogle Scholar
• Ryu M-O, Lee S-H, Ahn J-O, et al. Treatment of solid tumors in dogs using veterinary high-intensity focused ultrasound: a retrospective clinical study. Vet J. 2018;234:126–129.
   PubMed Web of Science ®Google Scholar
• Horise Y, Maeda M, Konishi Y, et al. Sonodynamic therapy with anticancer micelles and high-intensity focused ultrasound in treatment of canine cancer. Front Pharmacol. 2019;10:545–545.
   PubMed Web of Science ®Google Scholar
• Ranjan A, Kishore D, Ashar H, et al. Focused ultrasound ablation of a large canine oral tumor achieves efficient tumor remission: a case report. Int J Hyperthermia. 2021;38(1):552–560.
   PubMed Web of Science ®Google Scholar
• Spanoudes K, Evripidou N, Giannakou M, et al. A high intensity focused ultrasound system for veterinary oncology applications. J Med Ultrasound. 2021;29(3):195–202.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Gadaleta CD, Patruno R, et al. A model of study for human cancer: spontaneous occurring tumors in dogs: biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol. 2013;88(1):187–197.
   PubMed Web of Science ®Google Scholar
• Gustafson DL, Duval DL, Regan DP, et al. Canine sarcomas as a surrogate for the human disease. Pharmacol Ther. 2018;188:80–96.
   PubMed Web of Science ®Google Scholar
• Breen M, Modiano JF. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans – man and his best friend share more than companionship. Chromosome Res. 2008;16(1):145–154.
   PubMed Web of Science ®Google Scholar
• Knapp DW, Dhawan D, Ramos-Vara JA, et al. Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans. Front Oncol. 2019;9:1493.
   PubMed Web of Science ®Google Scholar
• de Brot S, Robinson B, Scase T, et al. The dog as an animal model for bladder and urethral urothelial carcinoma: comparative epidemiology and histology. Oncol Lett. 2018;16(2):1641–1649.
   PubMed Web of Science ®Google Scholar
• Rabkin BA, Zderic V, Crum LA, et al. Biological and physical mechanisms of HIFU-induced hyperecho in ultrasound images. Ultrasound Med Biol. 2006;32(11):1721–1729.
   PubMed Web of Science ®Google Scholar
• Wohlsein P, Peters M, Schulze C, et al. Thermal injuries in veterinary forensic pathology. Vet Pathol. 2016;53(5):1001–1017.
   PubMed Web of Science ®Google Scholar
• LeBlanc AK, Atherton M, Bentley RT, et al. Veterinary cooperative oncology Group-Common terminology criteria for adverse events (VCOG-CTCAE v2) following investigational therapy in dogs and cats. Vet Comp Oncol. 2021;19(2):311–352.
   PubMed Web of Science ®Google Scholar
• Bray JP, Polton GA, McSporran KD, et al. Canine soft tissue sarcoma managed in first opinion practice: outcome in 350 cases. Vet Surg. 2014;43(7):774–782.
   PubMed Web of Science ®Google Scholar
• Milovancev M, Tuohy JL, Townsend KL, et al. Influence of surgical margin completeness on risk of local tumour recurrence in canine cutaneous and subcutaneous soft tissue sarcoma: a systematic review and Meta-analysis. Vet Comp Oncol. 2019;17(3):354–364.
   PubMed Web of Science ®Google Scholar